Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
TEVA PHARMA
Dec-13
TORRENT PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7233,479-   
Low Rs1,2433,022-   
Sales per share (Unadj.) Rs284.21,996.4-  
Earnings per share (Unadj.) Rs36.8124.7-  
Cash flow per share (Unadj.) Rs57.7286.1-  
Dividends per share (Unadj.) Rs22.00109.18-  
Avg Dividend yield %1.53.4 44.2%  
Book value per share (Unadj.) Rs183.12,217.6-  
Shares outstanding (eoy) m338.45848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.21.6 320.4%   
Avg P/E ratio x40.326.1 154.6%  
P/CF ratio (eoy) x25.711.4 226.3%  
Price / Book Value ratio x8.11.5 552.4%  
Dividend payout %59.887.5 68.3%   
Avg Mkt Cap Rs m501,7792,756,220 18.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m16,7770-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m96,2021,692,969 5.7%  
Other income Rs m6320-   
Total revenues Rs m96,8341,692,969 5.7%   
Gross profit Rs m28,240463,620 6.1%  
Depreciation Rs m7,066136,844 5.2%   
Interest Rs m3,33433,253 10.0%   
Profit before tax Rs m18,472293,523 6.3%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m6,019-3,584 -168.0%   
Profit after tax Rs m12,452105,758 11.8%  
Gross profit margin %29.427.4 107.2%  
Effective tax rate %32.6-1.2 -2,669.1%   
Net profit margin %12.96.2 207.2%  
BALANCE SHEET DATA
Current assets Rs m53,1371,143,425 4.6%   
Current liabilities Rs m54,473997,163 5.5%   
Net working cap to sales %-1.48.6 -16.1%  
Current ratio x1.01.1 85.1%  
Inventory Days Days1591 17.1%  
Debtors Days Days796 7.7%  
Net fixed assets Rs m91,390552,961 16.5%   
Share capital Rs m1,6924,167 40.6%   
"Free" reserves Rs m60,2880-   
Net worth Rs m61,9811,880,567 3.3%   
Long term debt Rs m24,962865,653 2.9%   
Total assets Rs m144,6823,868,976 3.7%  
Interest coverage x6.59.8 66.5%   
Debt to equity ratio x0.40.5 87.5%  
Sales to assets ratio x0.70.4 152.0%   
Return on assets %10.93.6 303.7%  
Return on equity %20.15.6 357.2%  
Return on capital %25.14.9 508.6%  
Exports to sales %21.80-   
Imports to sales %00-   
Net fx Rs m17,2590-   
CASH FLOW
From Operations Rs m23,681269,772 8.8%  
From Investments Rs m-24,153-95,591 25.3%  
From Financial Activity Rs m774-323,609 -0.2%  
Net Cashflow Rs m1,101-149,429 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare TORRENT PHARMA With: PHARMAIDS PH  KIMIA BIOSCIENCES  EMMESSAR CHM  MESCO PHARMA  TYCHE INDUSTRIES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.